IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA – T B or MYELOID Test
Test Name: IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA – T B or MYELOID Test
Components: Price 2110.0 AED
Sample Condition: 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear. Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Clinical history is mandatory.
Report Delivery: Sample Daily by 9 am; Report Same day
Method: Flow Cytometry
Test type: Leukemias
Doctor: Oncologist, Hematologist
Test Department: FLOW CYTOMETRY
Pre Test Information: Clinical history is mandatory.
Test Details:
The Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel is a test used to identify and classify different types of leukemia. This specific panel is used for the diagnosis of acute leukemia and is designed to differentiate between T-cell, B-cell, or myeloid lineage leukemias. Flow cytometry is a technique that allows for the analysis of individual cells based on their surface markers or antigens. By using a combination of fluorescently labeled antibodies specific to different cell markers, flow cytometry can identify and quantify different cell populations within a sample.
In the case of acute leukemia, flow cytometry can help determine the lineage of the abnormal cells present in the blood or bone marrow. The T-cell, B-cell, or myeloid panel consists of a set of antibodies that specifically bind to markers expressed on these cell types. By analyzing the pattern of marker expression on the abnormal cells, the flow cytometry results can help differentiate between T-cell, B-cell, or myeloid lineage leukemias.
This information is crucial for the diagnosis and classification of acute leukemia, as it helps guide treatment decisions and prognosis. Different types of acute leukemia require different treatment approaches, and accurate classification is essential for appropriate management.
Overall, the Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel, specifically the T-cell, B-cell, or myeloid test, is a valuable tool in the diagnosis and classification of acute leukemia, providing important information for treatment decisions and patient care.
| Test Name | IMMUNOPHENOTYPING BY FLOW CYTOMETRY LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA – T B or MYELOID Test |
|---|---|
| Components | |
| Price | 2110.0 AED |
| Sample Condition | 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear. Ship immediately at 18\u0192??22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Clinical history is mandatory. |
| Report Delivery | Sample Daily by 9 am; Report Same day |
| Method | Flow Cytometry |
| Test type | Leukemias |
| Doctor | Oncologist, Hematologist |
| Test Department: | FLOW CYTOMETRY |
| Pre Test Information | Clinical history is mandatory. |
| Test Details | The Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel is a test used to identify and classify different types of leukemia. This specific panel is used for the diagnosis of acute leukemia and is designed to differentiate between T-cell, B-cell, or myeloid lineage leukemias. Flow cytometry is a technique that allows for the analysis of individual cells based on their surface markers or antigens. By using a combination of fluorescently labeled antibodies specific to different cell markers, flow cytometry can identify and quantify different cell populations within a sample. In the case of acute leukemia, flow cytometry can help determine the lineage of the abnormal cells present in the blood or bone marrow. The T-cell, B-cell, or myeloid panel consists of a set of antibodies that specifically bind to markers expressed on these cell types. By analyzing the pattern of marker expression on the abnormal cells, the flow cytometry results can help differentiate between T-cell, B-cell, or myeloid lineage leukemias. This information is crucial for the diagnosis and classification of acute leukemia, as it helps guide treatment decisions and prognosis. Different types of acute leukemia require different treatment approaches, and accurate classification is essential for appropriate management. Overall, the Immunophenotyping by Flow Cytometry: Leukemia Diagnostic Panel, specifically the T-cell, B-cell, or myeloid test, is a valuable tool in the diagnosis and classification of acute leukemia, providing important information for treatment decisions and patient care. |
